Macrogen, a South Korean biotech giant firm, is to implement blockchain for the distribution of genomic information in association with Big Data firm Bigster. The implementation of blockchain technology could reduce the risk of hacking or infringement of the database. The platform is expected to ease the distribution of genetic data.
Biotech Firm to Implement Blockchain Technology for Genetic DataIncryptsAug 07, 20180
13 hours ago
Apr 22, 2019
Apr 17, 2019
Apr 16, 2019